Get started
Author

Katharina F. Feister

The Ubiquitin-Specific Protease USP15 Promotes RIG-I–Mediated Antiviral Signaling by Deubiquitylating TRIM25
2014 · Eva-Katharina Pauli, Ying Kai Chan, et al. · Science Signaling · 152
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling
2017 · Cindy Chiang, Eva-Katharina Pauli, et al. · Journal of Virology · 138
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC : A Multi-institutional Retrospective Study
2022 · Michael J. Nathenson, Junxiao Hu, et al. · Clinical Cancer Research · 30
PDF
MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis
2021 · Ty K. Subhawong, Katharina Feister, et al. · Radiology Imaging Cancer · 29
RadioGraphics Update: New Follow-up and Management Recommendations for Polypoid Lesions of the Gallbladder
2023 · Katerina S. Konstantinoff, Katharina F. Feister, et al. · Radiographics · 9
Pearls and Pitfalls of Imaging Small Bowel Obstruction
2024 · Katharina Feister, Katerina Konstantinoff, et al. · Canadian Association of Radiologists Journal · 7
Abstract B36: Compassionate use of an oncolytic adenovirus in a Stage IV treatment-refractory ovarian cancer patient
2017 · Katharina Feister, Sara Collins, et al. · Clinical Cancer Research · 1
Optimizing Sonographic Analysis of Superficial Soft-Tissue Masses
2026 · Katerina S. Konstantinoff, Katharina F. Feister, et al. · Radiographics
Secondary peritoneal leiomyomatosis after uterine leiomyoma intervention: multi-institutional clinical and radiologic experience
2026 · Leslie W Nelson, Mark D Sugi, et al. · Abdominal Radiology
PDF
Aortoiliofemoral Lower Extremity CT Angiography
2025 · Anup S. Shetty, Mark J. Hoegger, et al. · Radiographics
Biparametric Prostate MRI: A Promising Shift in Prostate Cancer Imaging
2025 · Katharina F. Feister, Vincent M. Mellnick · Canadian Association of Radiologists Journal
Global Splenic Infarction From Thoracic Aortic Mobile Thrombus
2025 · Anup S. Shetty, Daniel R. Ludwig, et al. · Roentgen Ray Review
Cardiothoracic Conditions with Female Preponderance: Case-based Imaging Review
2023 · Katharina F. Feister, Katerina S. Konstantinoff, et al. · Radiographics
PDF
Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
PDF
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
PDF
Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
PDF
Supplementary Data from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Supplementary Figure from Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
2023 · Michael J. Nathenson, Junxiao Hu, et al.
Works count: 25
Citation count: 366
H-index: 6
I10-index: 4
Year
Topic
Type